Sartorius AG Stock
Stocks
SRT3
DE0007165631
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Xetra
11:36:12 2026-11-13 EST
|
5-day change | 1st Jan Change | ||
| 290.50 EUR | +1.18% |
|
+0.17% | +17.52% |
| 11-12 | Berenberg Research Boosts Sartorius PT, Maintains Buy Rating | MT |
| 11-12 | Berenberg Lifts Sartorius Price Target After 'Very Strong' Q3 Performance | MT |
| Market Cap | 17.83B 19.68B 16.49B 14.88B 28.04B 1,855B 29.03B 198B 78.56B 991B 73.84B 72.27B 3,146B | P/E 2026 * |
76.1x | P/E 2027 * | 58.8x |
|---|---|---|---|---|---|
| Enterprise Value | 21.41B 23.62B 19.8B 17.86B 33.67B 2,227B 34.85B 238B 94.31B 1,190B 88.65B 86.77B 3,777B | EV / Sales 2026 * |
5.73x | EV / Sales 2027 * | 5.13x |
| Free-Float |
35.87% | Yield 2026 * |
0.29% | Yield 2027 * | 0.34% |
| Markets | Quality | ||
|---|---|---|---|
Xetra
| SRT3 | Delayed | |
| SRT3d | Real-time | ||
| SRT3 | Real-time | ||
| SRT3 | Real-time | ||
| SRT3 | Delayed | ||
| SUVPF | Delayed | ||
| SRT3 | End-of-day quote | ||
| 0NIR | Delayed | ||
| SRT3 | Delayed | ||
| 0NIR | Real-time | ||
| SRT3 | Delayed | ||
| SRT3 | End-of-day quote | ||
| 1SRT3 | End-of-day quote |
Last Transcript: Sartorius AG
| 1 day | +1.18% | ||
| 1 week | +0.17% | ||
| Current month | -0.45% | ||
| 1 month | +10.96% | ||
| 3 months | +22.32% | ||
| 6 months | +41.78% | ||
| Current year | +17.52% |
| 1 week | 284.2 | 297.6 | |
| 1 month | 255.6 | 299.3 | |
| Current year | 198.5 | 299.3 | |
| 1 year | 198.5 | 299.3 | |
| 3 years | 166.05 | 383.7 | |
| 5 years | 166.05 | 631.6 | |
| 10 years | 63.65 | 631.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Grosse
CEO | Chief Executive Officer | 59 | 2025-06-29 |
Florian Funck
DFI | Director of Finance/CFO | 55 | 2024-03-31 |
Volker Niebel
COO | Chief Operating Officer | 70 | 2000-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Annette Becker
BRD | Director/Board Member | 62 | 2002-08-31 |
Lothar Kappich
CHM | Chairman | 69 | 2017-07-18 |
| Director/Board Member | 77 | 2011-11-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/1/26 | Free | Executive/Senior Manager | 4,268 | 0.0114% | ||
| 5/1/26 | Free | Executive/Senior Manager | 5,203 | 0.0139% | ||
| 3/12/26 | Buy | Chairman | 191 | 0.0005% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.18% | +0.17% | +26.14% | +6.41% | 19.68B | ||
| +0.11% | +0.79% | +21.00% | +48.81% | 259B | ||
| +0.37% | +1.20% | +5.34% | +11.94% | 164B | ||
| +0.84% | -2.03% | -19.28% | +51.28% | 154B | ||
| +0.32% | +3.72% | -56.82% | -17.66% | 64.27B | ||
| +1.28% | +4.91% | +24.16% | +59.90% | 61.61B | ||
| +0.34% | -1.59% | +0.18% | -11.01% | 53.94B | ||
| +0.55% | -0.46% | +18.49% | +53.13% | 49.04B | ||
| -0.29% | -0.72% | +2.78% | +70.57% | 48.82B | ||
| -0.42% | +0.58% | +21.31% | +72.42% | 45.24B | ||
| Average | +0.43% | +0.66% | +4.33% | +34.58% | 92B | |
| Weighted average by Cap. | +0.38% | +0.56% | +4.05% | +36.88% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.74B 4.12B 3.46B 3.12B 5.88B 389B 6.08B 41.52B 16.46B 208B 15.47B 15.15B 659B | 4.11B 4.54B 3.8B 3.43B 6.47B 428B 6.7B 45.7B 18.12B 229B 17.03B 16.67B 726B |
| Net income | 261M 288M 241M 218M 410M 27.13B 424M 2.9B 1.15B 14.49B 1.08B 1.06B 46B | 337M 371M 311M 281M 529M 35.02B 548M 3.74B 1.48B 18.71B 1.39B 1.36B 59.39B |
| Net Debt | 3.58B 3.95B 3.31B 2.98B 5.62B 372B 5.82B 39.73B 15.75B 199B 14.81B 14.49B 631B | 3.27B 3.6B 3.02B 2.73B 5.14B 340B 5.32B 36.28B 14.39B 182B 13.52B 13.24B 576B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-13 | €290.50 | +1.18% | 64,379 |
| 26-11-12 | €287.10 | -2.55% | 86,792 |
| 26-11-11 | €294.60 | +1.34% | 66,789 |
| 26-11-10 | €290.70 | -0.89% | 65,281 |
| 26-11-09 | €293.30 | +1.14% | 89,935 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- SRT3 Stock
Select your edition
All financial news and data tailored to specific country editions

















